Accessibility: If you are visually impaired or have some other impairment and you wish to discuss potential accommodations related to using this website, please contact our office at
(781) 396-8558.
Sleep apnea is not just a nightly inconvenience; it's a serious condition that can significantly impact your overall health and well-being. If you're seeking alternatives to traditional treatments like CPAP machines or invasive surgeries, there's exciting news on the horizon. Vivos Therapeutics has recently made history by receiving the first-ever FDA 510(k) clearance for its oral device treatment of severe obstructive sleep apnea (OSA). This groundbreaking achievement opens new doors for individuals struggling with sleep apnea, providing a non-invasive and effective option for treatment.
Before we explore the groundbreaking Vivos treatment, it's crucial to grasp the nuances of sleep apnea. Sleep apnea is a prevalent condition marked by intermittent pauses in breathing while asleep. Scientifically termed apneas, these pauses can manifest numerous times each hour, disrupting the natural sleep cycle and causing fragmented rest. The origins of sleep apnea are diverse, stemming from factors such as obesity, anatomical considerations, and lifestyle choices.
Understanding these aspects of sleep apnea is pivotal in appreciating the significance of innovative treatments like Vivos. By addressing the root causes of this condition, Vivos offers a unique approach to restoring restful sleep and mitigating the potential risks associated with untreated sleep apnea.
Vivos Therapeutics, Inc., a leading medical device and technology company, specializes in developing highly effective proprietary treatments for sleep-related breathing disorders. Their latest achievement involves the FDA clearance of the Vivos CARE (Complete Airway Repositioning and/or Expansion) oral appliances for treating severe obstructive sleep apnea in adults.
The Vivos method introduces a truly non-invasive approach to treating sleep apnea, offering a clear alternative to CPAP machines and surgical interventions. The Vivos CARE appliances, including the DNA, mRNA, and mmRNA oral appliances, have shown promising results in clinical trials.
This landmark decision by the FDA is a game-changer, especially for those who have struggled with severe OSA and found other treatments ineffective. It broadens the available treatment options and paves the way for increased collaboration between medical professionals and Vivos-trained providers.
If you suffer from sleep apnea, Vivos' FDA-cleared treatment might be the solution you've been looking for. The Vivos method is designed to comprehensively address OSA and associated conditions across a range of severity levels. With the flexibility to treat patients without regard to the severity of their OSA condition, Vivos opens up new possibilities for those who may not have found relief with traditional treatments. Before deciding on a treatment plan, it's crucial to consult with experts like those at Divine Smiles, who can assess your eligibility and provide personalized guidance.
The FDA clearance of Vivos' oral devices for severe obstructive sleep apnea marks a pivotal moment in sleep medicine. With proven effectiveness, shorter treatment times, and a non-invasive approach, Vivos is reshaping the landscape of sleep apnea treatment. If you're ready to improve your sleep quality and overall well-being, consider exploring the Vivos Sleep Apnea Treatment with the guidance of experienced professionals.
Dr. Ryan Clancy and every member of our team are here to help guide you to your healthiest, most confident smile. Take the first step by scheduling a full assessment of your concerns, and begin designing your ideal smile and personalized treatment plan.